GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Entourage Health Corp (OTCPK:ETRGF) » Definitions » Capex-to-Operating-Cash-Flow

Entourage Health (Entourage Health) Capex-to-Operating-Cash-Flow : 0.14 (As of Dec. 2023)


View and export this data going back to 2017. Start your Free Trial

What is Entourage Health Capex-to-Operating-Cash-Flow?

Capex-to-Operating-Cash-Flow assesses how much of a company’s cash flow from operations is being devoted to capital expenditure. It’s also useful to distinguish whether the company is capital intensive or not.

Entourage Health's Capital Expenditure for the three months ended in Dec. 2023 was $-0.18 Mil. Its Cash Flow from Operations for the three months ended in Dec. 2023 was $1.36 Mil.

Hence, Entourage Health's Capex-to-Operating-Cash-Flow for the three months ended in Dec. 2023 was 0.14.


Entourage Health Capex-to-Operating-Cash-Flow Historical Data

The historical data trend for Entourage Health's Capex-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Entourage Health Capex-to-Operating-Cash-Flow Chart

Entourage Health Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Capex-to-Operating-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Entourage Health Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Capex-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 1.08 0.14

Competitive Comparison of Entourage Health's Capex-to-Operating-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, Entourage Health's Capex-to-Operating-Cash-Flow, along with its competitors' market caps and Capex-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Entourage Health's Capex-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Entourage Health's Capex-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Entourage Health's Capex-to-Operating-Cash-Flow falls into.



Entourage Health Capex-to-Operating-Cash-Flow Calculation

Entourage Health's Capex-to-Operating-Cash-Flow for the fiscal year that ended in Dec. 2023 is calculated as

Capex-to-Operating-Cash-Flow=- Capital Expenditure / Cash Flow from Operations
=- (-0.894) / -7.633
=N/A

Entourage Health's Capex-to-Operating-Cash-Flow for the quarter that ended in Dec. 2023 is calculated as

Capex-to-Operating-Cash-Flow=- Capital Expenditure / Cash Flow from Operations
=- (-0.184) / 1.362
=0.14

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Entourage Health  (OTCPK:ETRGF) Capex-to-Operating-Cash-Flow Explanation

Capex-to-Operating-Cash-Flow ratio assesses how much of a company’s Cash Flow from Operations is being devoted to Capital Expenditure. It is a good indicator in terms of how much the company is focused on growth. In general, a high Capex-to-Operating-Cash-Flow ratio indicates that the company is investing more in physical assets and is focused on growth and expansion. Conversely, lower ratio could indicate that a company has reached maturity and is no longer pursuing aggressive growth.

Moreover, the ratio is also useful to distinguish whether the company is capital intensive or not. If the ratio is large, then the company tends to be capital intensive. Lower ratio suggests that it’s a capital-light business. The ratio can be combined with ROIC % to identify whether the company is an asset-light business that has a high return on invested capital. This is one question investors commonly ask to see if a company qualifies as a good company.


Entourage Health Capex-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Entourage Health's Capex-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Entourage Health (Entourage Health) Business Description

Traded in Other Exchanges
Address
250 Elm Street, Aylmer, ON, CAN, N5H 2M8
Entourage Health Corp is a licence holder producing and distributing cannabis products for both the medical and adult-use markets. It owns and operates greenhouse, outdoor, and processing facility located in Strathroy as well as a fully licensed Aylmer processing facility, specializing in cannabis extraction. With the addition of Starseed Medicinal, a medical-centric brand, it has expanded its multi-channeled distribution. The company operates in one segment, the production and sale of cannabis in Canada.